top of page

IPP Publications - Maladie de la Peyronie

 

Publications pour l'Oncologie

 

Liste de publications pour l'Urologie fonctionnelle

 

 

  1. Fontanella UA, et al. Iontophoretic Local Anaeshesia for Bladder Dilatation in the Treatment of Interstitial Cystitis. Br J Urol., 1992; 69 (6): 662-663.

 

  1. Lugnani F, et al. Iontophoresis of drugs in the bladder wall: equipment and preliminary studies. Art Org 1993; 171 (1): 8-17.

 

  1. Gürpinar T, et al. Electromotive drug administration to the urinary bladder: an animal model and preliminary results. J Urol 1996; 156: 1496-1501. 

 

  1. Gürpinar T, et al. Electromotive administration of intravesical lidocaine in patients with interstitial cystitis. J Endourol; 1996; 10 (5): 443-447.

 

  1. Fontanella UA, et al. Bladder and urethral anaesthesia with electromotive drug administration (EMDA): an adequate technique for invasive endoscopic procedures. Br J Urol 1997; 79: 414-420.

 

  1. Rosamilia A, et al. Electromotive drug administration of lidocaine and dexamethasone followed by cystodistension in women with interstitial cystitis. Int Urogynecol J 1997; 8: 142-145.

 

  1. Riedl CR, et al. Intravesical electromotive drug administration for the treatment of non-infectious chronic cystitis. Int Urogynecol 1997; 8: 134-137.

 

  1. Di Stasi S, et al. Electromotive administration of oxybutynin into the human bladder wall. J Urol 1997; 158: 228-233.

 

  1. Dasgupta P, et al. Electromotive drug administration of lidocaine to anesthetize the bladder before intravesical capsaicin. J Urol 1998; 159: 1857-1861.

 

  1. Riedl CR, et al. Electromotive drug administration and hydrodistension for the treatment of interstitial cystitis. J Endourol 1998; 12 (3): 269-272.

 

  1. Riedl CR, et al. Intravesical electromotive drug administration technique: preliminary results and side effects. J Urol 1998; 159: 1851-1856.

 

  1. Jewett MAS, et al. Electromotive drug administration of lidocaine as an alternative anesthesia for transurethral surgery. J Urol 1999; 161: 482-485.

 

13.J Urol 2000, 164: 2108-2111.

 

14.Di Stasi SM, et al. J Urol 2001, 165: 491-498.

 

15.Di Stasi SM, et al. J Urol 2001, 166: 2232-2236.

 

  1. Di Stasi SM et al. The stability of lidocaine and epinephrine solutions exposed to electric current and comparative administration rates of the two drugs into pig bladder wall. Urol Res 2003, 31: 169-176.

 

  1. Rose AE, Payne CK and Azevedo K. Pilot studyof the feasibility of In-Office bladder distension using Electromotive Drug Administration (EMDA). Neur and Urodyn 24: 1 – 7, 2005.

 

  1. Rose AE, Azevedo K and Payne CK. Office bladder distension with Electromotive Drug Administration (EMDA) is equivalent under General Anesthesia (GA). BMC Urology 2005, 5:14

 

 

 

  1. Riedl CR, et al. Iontophoresis for treatment of Peyronie’s disease. J Urol 2000; 163: 95-99.

 

  1. Montorsi F, et al. Transdermal electromotive multi-drug administration for Peyronie's disease: preliminary results. J Andrology 2000; 21 (1): 85-90

 

3.Levine LA et al. Tunica albuginea tissue analysis after electromotive drug administration. J Urol 2003, 169: 1775-1778.

 

  1. Di Stasi SM et al. Transdermal electromotive administration of verapamil and dexamethasone for Peyronie’s disease. BJU Intl 2003, 91: 825-829.

 

  1. Di Stasi SM et al. A prospective randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie’s disease. J Urol 2004, 174: 1605-1608.

 

 

 

 

 

 

  1. Di Stasi S, et al. Electromotive delivery of Mitomycin C into human bladder wall. Cancer Res 1997; 57: 875-880.

 

  1. Brausi M, et al. Intravesical electromotive administration (EMDA) of drugs for treatment of superficial bladder cancer: a comparative phase II study. Urol 1998; 51 (3): 506-509.

 

  1. Riedl CR, et al. Intravesical electromotive drug administration technique: preliminary results and side effects. J Urol 1998; 159: 1851-1856

 

  1. Di Stasi SM, et al. Electromotive versus passive diffusion of mitomycin C into human bladder wall: concentration-depth profiles studies. Cancer Res 1999; 59: 4912-4918.

 

5.Di Stasi SM et al. J Urol 2003, 170: 777-782.

 

  1. Di Stasi SM et al. Percutaneous sequential bacillus Calmette-Guèrin and mitomycin C for panurothelial carcinomatosis. Can J Urol 2005, 12(6): 2895-2898

 

  1. Di Stasi SM et al. Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial. The Lancet Oncol 2006, 7: 43-51

 

  1. Di Stasi SM, Riedl C: Updates in intravesical electromotive drug administration of mitomycin-C for non-muscle invasive bladder cancer. World J Urol, published on line on 21 February 2009

 

  1. Di Stasi SM et al. Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial. Lancet Oncol 2011; 12: 871-79

 

  1. Vasquez JL et al. Electroporation enhances mitomycin C cytotoxicity on T24 bladder cancer cell line:A potential improvement of intravesical chemotherapy in bladder cancer.  Bioelectrochemistry 88 (2012) 127-133

 

 

 

 

Sede legale e ammi.va: Via Fogazzaro 4/B - 41037 Mirandola MO - ItalyTel +39 0535 611082 Fax +39 0535 610420 Cod Fisc e P.IVA 01990130369
email: info@physion.it
Copyright 2013©Physion.it
  • Wix Facebook page
  • Wix Twitter page
  • Wix Google+ page
Suivez Physion sur les réseaux sociaux les plus populaires
bottom of page